Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3403473 | Indian Journal of Tuberculosis | 2016 | 6 Pages |
Abstract
BCG, the only available vaccine, though prevents against severe form of primary tuberculosis in paediatric population, failed to have its efficacy in pulmonary patients. Few candidates are in the pipeline undergoing clinical trial. An extensive research is needed to ensure their safety and efficacy before their acceptance as a TB vaccine to be incorporated in national immunization programmes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
Salil Bhargava, Satyadeo Choubey, Satyendra Mishra,